Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Cortisone-acetate | hsa00030 | Pentose phosphate pathway | 8.97E-03 | 1 | P11413 | G6PD | More | | Cortisone-acetate | hsa00071 | Fatty acid degradation | 3.77E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | | Cortisone-acetate | hsa00480 | Glutathione metabolism | 1.35E-02 | 1 | P11413 | G6PD | More | | Cortisone-acetate | hsa00500 | Starch and sucrose metabolism | 2.10E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Cortisone-acetate | hsa00970 | Aminoacyl-tRNA biosynthesis | 9.32E-03 | 3 | O95363, P54136, Q15046 | FARS2, RARS1, KARS | More | | Cortisone-acetate | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | | Cortisone-acetate | hsa03013 | RNA transport | 8.19E-04 | 7 | Q15287, Q9UBU9, P35658, P63279, P55884, O15371, P20042 | RNPS1, NXF1, NUP214, UBE2I, EIF3B, EIF3D, EIF2S2 | More | | Cortisone-acetate | hsa03040 | Spliceosome | 3.98E-02 | 4 | Q15427, P38159, P61978, P11142 | SF3B4, RBMX, HNRPK, HSPA8 | More | | Cortisone-acetate | hsa03060 | Protein export | 9.07E-04 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Cortisone-acetate | hsa04012 | ErbB signaling pathway | 3.74E-02 | 3 | P21860, Q13557, O14944 | ERBB3, CAMK2D, EREG | More | | Cortisone-acetate | hsa04020 | Calcium signaling pathway | 2.19E-05 | 10 | Q96DU7, Q08828, P45880, Q13557, P21860, P61073, P0DP24, P05141, P51828, P23634 | ITPKC, ADCY1, VDAC2, CAMK2D, ERBB3, CXCR4, CALM2, SLC25A5, ADCY7, ATP2B4 | More | | Cortisone-acetate | hsa04022 | cGMP-PKG signaling pathway | 2.45E-03 | 8 | Q99941, P18848, P23634, Q08828, P51828, P05141, P45880, P0DP24 | CREBL1, ATF4, ATP2B4, ADCY1, ADCY7, SLC25A5, VDAC2, CALM2 | More | | Cortisone-acetate | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.91E-02 | 3 | Q8NHW4, P61073, Q13651 | CCL4L2, CXCR4, IL10RA | More | | Cortisone-acetate | hsa04064 | NF-kappa B signaling pathway | 1.06E-05 | 15 | P10415, Q13489, O00463, Q13546, P01584, Q04759, Q9UDY8, Q16548, Q13315, P63279, P24522, Q8NHW4, P09341, Q9UNE0, Q9NQC7 | BCL2, BIRC3, TRAF5, RIPK1, IL1B, PRKCQ, MALT1, BCL2A1, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, EDAR, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.708 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P01584 | IL1B | Interleukin-1 beta | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.815 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UNE0 | EDAR | Tumor necrosis factor receptor superfamily member EDAR | 0.819 | P01584 | IL1B | Interleukin-1 beta | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.805 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.708 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P01584 | IL1B | Interleukin-1 beta | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.815 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UNE0 | EDAR | Tumor necrosis factor receptor superfamily member EDAR | 0.819 | P01584 | IL1B | Interleukin-1 beta | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.805 |
| Cortisone-acetate | hsa04071 | Sphingolipid signaling pathway | 1.19E-02 | 5 | P21453, Q9H228, Q13362, Q9BX95, P10415 | S1PR1, EDG8, PPP2R5C, SGPP1, BCL2 | More | | Cortisone-acetate | hsa04080 | Neuroactive ligand-receptor interaction | 1.23E-03 | 10 | P08311, P48058, Q15722, P21453, Q9H228, P43657, O00398, P21730, P07550, P35318 | CTSG, GRIA4, LTB4R, S1PR1, EDG8, P2RY5, P2RY10, C5AR1, ADRB2, ADM | More | | Cortisone-acetate | hsa04114 | Oocyte meiosis | 4.36E-02 | 5 | Q13557, P0DP24, Q08828, P51828, P27348 | CAMK2D, CALM2, ADCY1, ADCY7, YWHAQ | More | | Cortisone-acetate | hsa04140 | Autophagy - animal | 3.19E-02 | 4 | P22694, Q14643, P10415, Q04759 | PRKACB, ITPR1, BCL2, PRKCQ | More | | Cortisone-acetate | hsa04141 | Protein processing in endoplasmic reticulum | 3.64E-02 | 5 | Q99941, O75460, P11142, Q9H3Z4, P07900 | CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1 | More | | Cortisone-acetate | hsa04145 | Phagosome | 4.48E-02 | 5 | Q15080, P05164, O60603, P35443, P13765 | NCF4, MPO, TLR2, THBS4, HLA-DOB | More | | Cortisone-acetate | hsa04210 | Apoptosis | 3.44E-02 | 7 | Q13315, P10415, O76075, P24522, Q16548, P43234, Q14643 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ITPR1 | More | | Cortisone-acetate | hsa04211 | Longevity regulating pathway | 3.41E-03 | 7 | Q12778, Q08828, P51828, Q99941, P18848, Q9UEF7, Q96KQ7 | FOXO1, ADCY1, ADCY7, CREBL1, ATF4, KL, EHMT2 | More | | Cortisone-acetate | hsa04217 | Necroptosis | 6.23E-04 | 10 | P01568, P23458, Q13489, Q9NQC7, Q13546, P05141, P01584, P0C0S5, Q13557, Q9H444 | IFNA21, JAK1, BIRC3, CYLD, RIPK1, SLC25A5, IL1B, H2AFZ, CAMK2D, CHMP4B | More | | Cortisone-acetate | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.60E-03 | 7 | Q08828, P51828, Q99941, P18848, P0DP24, Q13557, P23634 | ADCY1, ADCY7, CREBL1, ATF4, CALM2, CAMK2D, ATP2B4 | More | | Cortisone-acetate | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Cortisone-acetate | hsa04340 | Hedgehog signaling pathway | 3.09E-02 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | | Cortisone-acetate | hsa04380 | Osteoclast differentiation | 4.98E-02 | 4 | Q9NQC7, Q9UQC2, P23458, P01584 | CYLD, GAB2, JAK1, IL1B | More | | Cortisone-acetate | hsa04612 | Antigen processing and presentation | 4.48E-02 | 5 | P13765, P26715, P26717, Q13241, P01732 | HLA-DOB, KLRC1, KLRC2, KLRD1, CD8A | More | | Cortisone-acetate | hsa04613 | Neutrophil extracellular trap formation | 4.93E-02 | 8 | O60603, P05164, P08246, Q9UM07, Q15080, P20160, P08311, P21730 | TLR2, MPO, ELA2, PADI4, NCF4, AZU1, CTSG, C5AR1 | More | | Cortisone-acetate | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | | Cortisone-acetate | hsa04621 | NOD-like receptor signaling pathway | 4.72E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | | Cortisone-acetate | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Cortisone-acetate | hsa04623 | Cytosolic DNA-sensing pathway | 5.86E-05 | 4 | P01584, P01568, Q13546, Q8NHW4 | IL1B, IFNA21, RIPK1, CCL4L2 | More | | Cortisone-acetate | hsa04640 | Hematopoietic cell lineage | 1.13E-02 | 8 | P13612, P14778, P27930, P15144, P07766, P09693, P01732, P01730 | ITGA4, IL1R1, IL1R2, ANPEP, CD3E, CD3G, CD8A, CD4 | More | | Cortisone-acetate | hsa04650 | Natural killer cell mediated cytotoxicity | 2.11E-04 | 9 | P78314, P06239, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | SH3BP2, LCK, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O43451 | MGAM | Maltase-glucoamylase | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.761 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | O43451 | MGAM | Maltase-glucoamylase | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.804 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.869 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | O43451 | MGAM | Maltase-glucoamylase | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.759 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | O43451 | MGAM | Maltase-glucoamylase | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.842 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.762 | O43451 | MGAM | Maltase-glucoamylase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.802 | O43451 | MGAM | Maltase-glucoamylase | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.71 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | O43451 | MGAM | Maltase-glucoamylase | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.71 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 | P01375 | TNF | Tumor necrosis factor | P01375 | TNF | Tumor necrosis factor | 1 | P12429 | ANXA3 | Annexin A3 | P01375 | TNF | Tumor necrosis factor | 0.832 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | P01375 | TNF | Tumor necrosis factor | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.717 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.869 | P12429 | ANXA3 | Annexin A3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.833 | P01375 | TNF | Tumor necrosis factor | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.727 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 | P01375 | TNF | Tumor necrosis factor | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.769 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | P12429 | ANXA3 | Annexin A3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.84 | P01375 | TNF | Tumor necrosis factor | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.754 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.762 | P12429 | ANXA3 | Annexin A3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.919 | P01375 | TNF | Tumor necrosis factor | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.838 | P12429 | ANXA3 | Annexin A3 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.816 | P01375 | TNF | Tumor necrosis factor | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.814 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | P12429 | ANXA3 | Annexin A3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.83 | P01375 | TNF | Tumor necrosis factor | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.814 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 | P12429 | ANXA3 | Annexin A3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.83 |
| Cortisone-acetate | hsa04658 | Th1 and Th2 cell differentiation | 4.60E-07 | 11 | Q04759, P07766, P20963, P09693, Q16539, P01730, P06239, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD3E, CD247, CD3G, MAPK14, CD4, LCK, STAT4, GATA3, TBX21, HLA-DOB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | O43451 | MGAM | Maltase-glucoamylase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.771 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | O43451 | MGAM | Maltase-glucoamylase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.799 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P12429 | ANXA3 | Annexin A3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.906 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.852 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.775 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P12429 | ANXA3 | Annexin A3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.769 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.84 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.825 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | P12429 | ANXA3 | Annexin A3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.769 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P12429 | ANXA3 | Annexin A3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.832 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.752 | P12429 | ANXA3 | Annexin A3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.858 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P12429 | ANXA3 | Annexin A3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.76 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.725 |
| Cortisone-acetate | hsa04659 | Th17 cell differentiation | 1.39E-05 | 11 | Q04759, Q16539, P01730, P06239, P13765, P14778, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, MAPK14, CD4, LCK, HLA-DOB, IL1R1, TBX21, GATA3, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | O43451 | MGAM | Maltase-glucoamylase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.924 | O43451 | MGAM | Maltase-glucoamylase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.799 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | O43451 | MGAM | Maltase-glucoamylase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.771 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P12429 | ANXA3 | Annexin A3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.906 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.84 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.825 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P12429 | ANXA3 | Annexin A3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.76 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.936 | P12429 | ANXA3 | Annexin A3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.749 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.752 | P12429 | ANXA3 | Annexin A3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.858 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P12429 | ANXA3 | Annexin A3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.832 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.852 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P12429 | ANXA3 | Annexin A3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.769 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.775 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 |
| Cortisone-acetate | hsa04660 | T cell receptor signaling pathway | 2.30E-05 | 13 | Q9UDY8, Q04759, P10747, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | MALT1, PRKCQ, CD28, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | O43451 | MGAM | Maltase-glucoamylase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.764 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | O43451 | MGAM | Maltase-glucoamylase | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.712 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | O43451 | MGAM | Maltase-glucoamylase | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.815 | P12429 | ANXA3 | Annexin A3 | P01375 | TNF | Tumor necrosis factor | 0.832 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P12429 | ANXA3 | Annexin A3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.906 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.751 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P12429 | ANXA3 | Annexin A3 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.77 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | P12429 | ANXA3 | Annexin A3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.836 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.852 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.775 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P12429 | ANXA3 | Annexin A3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.769 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.84 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | P12429 | ANXA3 | Annexin A3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.77 | P12429 | ANXA3 | Annexin A3 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.814 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.825 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | P12429 | ANXA3 | Annexin A3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.743 |
| Cortisone-acetate | hsa04668 | TNF signaling pathway | 4.74E-02 | 3 | Q99941, P01584, O95429 | CREBL1, IL1B, BAG4 | More | | Cortisone-acetate | hsa04713 | Circadian entrainment | 1.91E-02 | 4 | P0DP24, Q13557, Q08828, P51828 | CALM2, CAMK2D, ADCY1, ADCY7 | More | | Cortisone-acetate | hsa04720 | Long-term potentiation | 1.91E-02 | 4 | Q13557, P0DP24, P18848, Q08828 | CAMK2D, CALM2, ATF4, ADCY1 | More | | Cortisone-acetate | hsa04725 | Cholinergic synapse | 3.77E-02 | 4 | Q08828, P51828, P18848, Q13557 | ADCY1, ADCY7, ATF4, CAMK2D | More | | Cortisone-acetate | hsa04728 | Dopaminergic synapse | 2.67E-02 | 5 | Q99941, P18848, Q13557, P0DP24, O15516 | CREBL1, ATF4, CAMK2D, CALM2, CLOCK | More | | Cortisone-acetate | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.53E-04 | 5 | P01584, Q08828, P51828, Q13557, P0DP24 | IL1B, ADCY1, ADCY7, CAMK2D, CALM2 | More | | Cortisone-acetate | hsa04911 | Insulin secretion | 2.95E-05 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Cortisone-acetate | hsa04912 | GnRH signaling pathway | 6.99E-03 | 5 | Q08828, P51828, P18848, Q13557, P0DP24 | ADCY1, ADCY7, ATF4, CAMK2D, CALM2 | More | | Cortisone-acetate | hsa04915 | Estrogen signaling pathway | 4.72E-02 | 4 | Q99941, P51828, P07900, P11142 | CREBL1, ADCY7, HSP90AA1, HSPA8 | More | | Cortisone-acetate | hsa04916 | Melanogenesis | 7.61E-03 | 4 | Q13557, P0DP24, Q08828, P51828 | CAMK2D, CALM2, ADCY1, ADCY7 | More | | Cortisone-acetate | hsa04918 | Thyroid hormone synthesis | 4.47E-03 | 5 | Q08828, P51828, Q99941, P18848, P02768 | ADCY1, ADCY7, CREBL1, ATF4, ALB | More | | Cortisone-acetate | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | | Cortisone-acetate | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Cortisone-acetate | hsa04925 | Aldosterone synthesis and secretion | 8.00E-06 | 7 | Q99941, P18848, Q08828, P51828, P0DP24, Q13557, P23634 | CREBL1, ATF4, ADCY1, ADCY7, CALM2, CAMK2D, ATP2B4 | More | | Cortisone-acetate | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 4 | Q99941, P18848, Q08828, P51828 | CREBL1, ATF4, ADCY1, ADCY7 | More | | Cortisone-acetate | hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.92E-03 | 8 | Q14643, Q08828, P51828, P22694, P23771, Q99941, P18848, P10415 | ITPR1, ADCY1, ADCY7, PRKACB, GATA3, CREBL1, ATF4, BCL2 | More | | Cortisone-acetate | hsa04932 | Non-alcoholic fatty liver disease | 3.45E-02 | 5 | P18848, O75460, P01584, P12074, O15239 | ATF4, ERN1, IL1B, COX6A1, NDUFA1 | More | | Cortisone-acetate | hsa04934 | Cushing syndrome | 2.69E-06 | 6 | Q99941, P18848, Q08828, P51828, O15169, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, AXIN1, CAMK2D | More | | Cortisone-acetate | hsa04935 | Growth hormone synthesis, secretion and action | 4.98E-02 | 4 | Q08828, P51828, Q99941, P18848 | ADCY1, ADCY7, CREBL1, ATF4 | More | | Cortisone-acetate | hsa04970 | Salivary secretion | 3.54E-02 | 3 | Q08828, P51828, P0DP24 | ADCY1, ADCY7, CALM2 | More | | Cortisone-acetate | hsa04971 | Gastric acid secretion | 2.95E-05 | 5 | Q08828, P51828, P15311, P0DP24, Q13557 | ADCY1, ADCY7, VIL2, CALM2, CAMK2D | More | | Cortisone-acetate | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | | Cortisone-acetate | hsa05010 | Alzheimer disease | 2.62E-04 | 14 | Q92542, O15239, P05496, P12074, Q00535, O75460, P0DP24, P01584, P18848, O15169, P05141, P45880, P28070, P43686 | NCSTN, NDUFA1, ATP5G1, COX6A1, CDK5, ERN1, CALM2, IL1B, ATF4, AXIN1, SLC25A5, VDAC2, PSMB4, PSMC4 | More | | Cortisone-acetate | hsa05012 | Parkinson disease | 7.90E-03 | 9 | O15239, P12074, P05141, O75460, P18848, P28070, P43686, P0DP24, Q13557 | NDUFA1, COX6A1, SLC25A5, ERN1, ATF4, PSMB4, PSMC4, CALM2, CAMK2D | More | | Cortisone-acetate | hsa05016 | Huntington disease | 3.54E-02 | 8 | O15239, P12074, P24928, P62487, P05141, O75460, P28070, P43686 | NDUFA1, COX6A1, POLR2A, POLR2G, SLC25A5, ERN1, PSMB4, PSMC4 | More | | Cortisone-acetate | hsa05020 | Prion disease | 1.76E-03 | 12 | P01584, P46531, P11142, O15239, P05496, P12074, P18848, P05141, P45880, P28070, P43686, Q99941 | IL1B, NOTCH1, HSPA8, NDUFA1, ATP5G1, COX6A1, ATF4, SLC25A5, VDAC2, PSMB4, PSMC4, CREBL1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P01584 | IL1B | Interleukin-1 beta | 0.75 | P01584 | IL1B | Interleukin-1 beta | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.827 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.706 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P01584 | IL1B | Interleukin-1 beta | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.783 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.733 | P01584 | IL1B | Interleukin-1 beta | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.744 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.754 | P01584 | IL1B | Interleukin-1 beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.749 | P01584 | IL1B | Interleukin-1 beta | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.768 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.708 | P01584 | IL1B | Interleukin-1 beta | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.734 | P01584 | IL1B | Interleukin-1 beta | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.723 | P01584 | IL1B | Interleukin-1 beta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.704 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.769 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P01584 | IL1B | Interleukin-1 beta | 0.75 | P01584 | IL1B | Interleukin-1 beta | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.827 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.706 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P01584 | IL1B | Interleukin-1 beta | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.783 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.733 | P01584 | IL1B | Interleukin-1 beta | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.744 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.754 | P01584 | IL1B | Interleukin-1 beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.749 | P01584 | IL1B | Interleukin-1 beta | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.768 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.708 | P01584 | IL1B | Interleukin-1 beta | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.734 | P01584 | IL1B | Interleukin-1 beta | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.723 | P01584 | IL1B | Interleukin-1 beta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.704 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.769 |
| Cortisone-acetate | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.74E-03 | 13 | O15239, P12074, Q8TEV9, O75460, P18848, P05141, Q00535, O15169, P01584, P0DP24, Q13557, P28070, P43686 | NDUFA1, COX6A1, SMCR8, ERN1, ATF4, SLC25A5, CDK5, AXIN1, IL1B, CALM2, CAMK2D, PSMB4, PSMC4 | More | | Cortisone-acetate | hsa05030 | Cocaine addiction | 3.54E-02 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | | Cortisone-acetate | hsa05031 | Amphetamine addiction | 7.61E-03 | 4 | P0DP24, Q13557, Q99941, P18848 | CALM2, CAMK2D, CREBL1, ATF4 | More | | Cortisone-acetate | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 3.76E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Cortisone-acetate | hsa05132 | Salmonella infection | 9.85E-03 | 4 | Q13546, Q13489, O60282, P68371 | RIPK1, BIRC3, KIF5C, TUBB2C | More | | Cortisone-acetate | hsa05135 | Yersinia infection | 1.52E-02 | 6 | P13612, P06239, Q16539, P49841, P01730, P01732 | ITGA4, LCK, MAPK14, GSK3B, CD4, CD8A | More | | Cortisone-acetate | hsa05146 | Amoebiasis | 2.10E-02 | 6 | P09341, P14778, P27930, P05089, P12814, P08311 | CXCL1, IL1R1, IL1R2, ARG1, ACTN1, CTSG | More | | Cortisone-acetate | hsa05163 | Human cytomegalovirus infection | 2.62E-04 | 10 | P0DP24, Q8NHW4, Q08828, P51828, P23458, P01584, P61073, Q13651, Q99941, P18848 | CALM2, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, CXCR4, IL10RA, CREBL1, ATF4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P01584 | IL1B | Interleukin-1 beta | P0DP24 | CALM2 | Calmodulin-2 | 0.72 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.75 | P01584 | IL1B | Interleukin-1 beta | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.815 | P01584 | IL1B | Interleukin-1 beta | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.799 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P01584 | IL1B | Interleukin-1 beta | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.825 | P01584 | IL1B | Interleukin-1 beta | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.82 | P01584 | IL1B | Interleukin-1 beta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.704 | P01584 | IL1B | Interleukin-1 beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.749 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.751 | P12429 | ANXA3 | Annexin A3 | P01375 | TNF | Tumor necrosis factor | 0.832 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.733 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.875 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.728 | P12429 | ANXA3 | Annexin A3 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.75 | P01584 | IL1B | Interleukin-1 beta | P0DP24 | CALM2 | Calmodulin-2 | 0.72 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.75 | P01584 | IL1B | Interleukin-1 beta | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.815 | P12429 | ANXA3 | Annexin A3 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.754 | P01584 | IL1B | Interleukin-1 beta | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.799 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | P12429 | ANXA3 | Annexin A3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.936 | P12429 | ANXA3 | Annexin A3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.749 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P01584 | IL1B | Interleukin-1 beta | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.825 | P01584 | IL1B | Interleukin-1 beta | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.82 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.769 | P12429 | ANXA3 | Annexin A3 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.716 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.889 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.86 | P12429 | ANXA3 | Annexin A3 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.857 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | P01584 | IL1B | Interleukin-1 beta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.704 | P01584 | IL1B | Interleukin-1 beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.749 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.719 | P12429 | ANXA3 | Annexin A3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.896 |
| Cortisone-acetate | hsa05202 | Transcriptional misregulation in cancer | 2.90E-02 | 9 | Q12778, Q13315, P14780, Q16548, O15550, P05164, P08246, Q9C0K0, P24522 | FOXO1, ATM, MMP9, BCL2A1, UTX, MPO, ELA2, BCL11B, GADD45A | More | | Cortisone-acetate | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | | Cortisone-acetate | hsa05230 | Central carbon metabolism in cancer | 1.12E-02 | 1 | P11413 | G6PD | More | | Cortisone-acetate | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.09E-04 | 9 | P07766, P20963, P09693, P06239, O60603, P10747, Q04759, Q16539, P01730 | CD3E, CD247, CD3G, LCK, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.751 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.716 | P12429 | ANXA3 | Annexin A3 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.77 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.852 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.775 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.744 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P12429 | ANXA3 | Annexin A3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.769 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.825 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P12429 | ANXA3 | Annexin A3 | O60603 | TLR2 | Toll-like receptor 2 | 0.702 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P12429 | ANXA3 | Annexin A3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.906 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.707 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.84 |
| Cortisone-acetate | hsa05321 | Inflammatory bowel disease | 1.17E-03 | 5 | O60603, P13765, Q14765, Q9UL17, P23771 | TLR2, HLA-DOB, STAT4, TBX21, GATA3 | More | | Cortisone-acetate | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Cortisone-acetate | hsa05332 | Graft-versus-host disease | 3.45E-03 | 4 | P13765, P10747, P26715, Q13241 | HLA-DOB, CD28, KLRC1, KLRD1 | More | | Cortisone-acetate | hsa05340 | Primary immunodeficiency | 3.76E-02 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | | Cortisone-acetate | hsa05415 | Diabetic cardiomyopathy | 3.59E-02 | 1 | P11413 | G6PD | More | | Hydrocortisone-acetate | hsa00030 | Pentose phosphate pathway | 8.97E-03 | 1 | P11413 | G6PD | More | | Hydrocortisone-acetate | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Hydrocortisone-acetate | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Hydrocortisone-acetate | hsa00220 | Arginine biosynthesis | 1.94E-03 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Hydrocortisone-acetate | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.32E-02 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Hydrocortisone-acetate | hsa00480 | Glutathione metabolism | 2.60E-05 | 5 | Q9UJ14, P11413, Q16772, P09211, P30041 | GGTL3, G6PD, GSTA3, GSTP1, PRDX6 | More | | Hydrocortisone-acetate | hsa00500 | Starch and sucrose metabolism | 2.51E-06 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Hydrocortisone-acetate | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Hydrocortisone-acetate | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Hydrocortisone-acetate | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Hydrocortisone-acetate | hsa00730 | Thiamine metabolism | 5.11E-05 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Hydrocortisone-acetate | hsa00910 | Nitrogen metabolism | 4.32E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Hydrocortisone-acetate | hsa00970 | Aminoacyl-tRNA biosynthesis | 1.21E-02 | 1 | P14868 | DARS | More | | Hydrocortisone-acetate | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-05 | 4 | Q16772, P78417, P09211, P11712 | GSTA3, GSTO1, GSTP1, CYP2C9 | More | | Hydrocortisone-acetate | hsa00982 | Drug metabolism - cytochrome P450 | 1.77E-04 | 4 | P11712, Q16772, P09211, P78417 | CYP2C9, GSTA3, GSTP1, GSTO1 | More | | Hydrocortisone-acetate | hsa00983 | Drug metabolism - other enzymes | 8.59E-04 | 4 | P32320, P05164, Q16772, P09211 | CDA, MPO, GSTA3, GSTP1 | More | | Hydrocortisone-acetate | hsa01100 | Metabolic pathways | 3.55E-03 | 34 | Q9NR34, P35790, P05089, Q16772, P09211, Q9UJ14, P30041, P32320, P22748, P40926, P55809, P06280, Q16875, O43286, O43451, Q7KZN9, P05186, P24666, P15121, Q9HCC0, P33121, Q9UHK6, Q86VZ5, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q9BQB6 | MAN1C1, CHKA, ARG1, GSTA3, GSTP1, GGTL3, PRDX6, CDA, CA4, MDH2, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, COX15, ALPL, ACP1, AKR1B1, MCCC2, ACSL1, AMACR, SGMS1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, VKORC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P35790 | CHKA | Choline kinase alpha | -0.717 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.793 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P09211 | GSTP1 | Glutathione S-transferase P | 0.712 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | 0.748 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.75 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | 0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q7KZN9 | COX15 | Cytochrome c oxidase assembly protein COX15 homolog | 0.764 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.704 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.736 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9BQB6 | VKORC1 | Vitamin K epoxide reductase complex subunit 1 | 0.731 |
| Hydrocortisone-acetate | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | | Hydrocortisone-acetate | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-acetate | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Hydrocortisone-acetate | hsa03013 | RNA transport | 9.39E-05 | 9 | Q15287, Q9UBU9, P35658, P63279, P68104, P55884, O15371, P20042, Q14232 | RNPS1, NXF1, NUP214, UBE2I, EEF1A1, EIF3B, EIF3D, EIF2S2, EIF2B1 | More | | Hydrocortisone-acetate | hsa03040 | Spliceosome | 3.98E-02 | 4 | Q15427, P38159, P61978, P11142 | SF3B4, RBMX, HNRPK, HSPA8 | More | | Hydrocortisone-acetate | hsa03060 | Protein export | 9.07E-04 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Hydrocortisone-acetate | hsa04012 | ErbB signaling pathway | 3.74E-02 | 3 | P21860, Q13557, O14944 | ERBB3, CAMK2D, EREG | More | | Hydrocortisone-acetate | hsa04020 | Calcium signaling pathway | 2.19E-05 | 10 | Q96DU7, Q08828, P45880, Q13557, P21860, P61073, P0DP24, P05141, P51828, P23634 | ITPKC, ADCY1, VDAC2, CAMK2D, ERBB3, CXCR4, CALM2, SLC25A5, ADCY7, ATP2B4 | More | | Hydrocortisone-acetate | hsa04022 | cGMP-PKG signaling pathway | 2.45E-03 | 8 | Q99941, P18848, P23634, Q08828, P51828, P05141, P45880, P0DP24 | CREBL1, ATF4, ATP2B4, ADCY1, ADCY7, SLC25A5, VDAC2, CALM2 | More | | Hydrocortisone-acetate | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 9.15E-04 | 9 | Q8NHW4, P09341, P25024, P25025, P61073, P47992, Q9UBD3, Q13651, P01375 | CCL4L2, CXCL1, CXCR1, CXCR2, CXCR4, XCL1, XCL2, IL10RA, TNF | More | | Hydrocortisone-acetate | hsa04062 | Chemokine signaling pathway | 3.13E-02 | 8 | P25024, P25025, P07948, P42338, P63218, P50151, P49407, P49841 | CXCR1, CXCR2, LYN, PIK3CB, GNG5, GNG10, ARRB1, GSK3B | More | | Hydrocortisone-acetate | hsa04064 | NF-kappa B signaling pathway | 1.32E-06 | 18 | P10415, Q13489, O00463, Q13546, P14778, P01584, Q04759, Q9UDY8, Q13077, Q16548, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, Q9UNE0, Q9NQC7 | BCL2, BIRC3, TRAF5, RIPK1, IL1R1, IL1B, PRKCQ, MALT1, TRAF1, BCL2A1, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, EDAR, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.708 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P01584 | IL1B | Interleukin-1 beta | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.815 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UNE0 | EDAR | Tumor necrosis factor receptor superfamily member EDAR | 0.819 | P01584 | IL1B | Interleukin-1 beta | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.805 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.708 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P01584 | IL1B | Interleukin-1 beta | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.815 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UNE0 | EDAR | Tumor necrosis factor receptor superfamily member EDAR | 0.819 | P01584 | IL1B | Interleukin-1 beta | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.805 |
| Hydrocortisone-acetate | hsa04071 | Sphingolipid signaling pathway | 7.26E-04 | 7 | P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2 | More | | Hydrocortisone-acetate | hsa04080 | Neuroactive ligand-receptor interaction | 1.00E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | | Hydrocortisone-acetate | hsa04114 | Oocyte meiosis | 4.36E-02 | 5 | Q13557, P0DP24, Q08828, P51828, P27348 | CAMK2D, CALM2, ADCY1, ADCY7, YWHAQ | More | | Hydrocortisone-acetate | hsa04120 | Ubiquitin mediated proteolysis | 2.57E-02 | 4 | Q14145, Q13042, Q93034, Q15751 | KEAP1, CDC16, CUL5, HERC1 | More | | Hydrocortisone-acetate | hsa04140 | Autophagy - animal | 3.05E-03 | 6 | Q9NQL2, P22694, Q14643, P10415, Q9H1Y0, Q04759 | RRAGD, PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Hydrocortisone-acetate | hsa04141 | Protein processing in endoplasmic reticulum | 5.75E-03 | 7 | Q99941, O75460, P17861, P11142, Q9H3Z4, P07900, Q9NR31 | CREBL1, ERN1, XBP1, HSPA8, DNAJC5, HSP90AA1, SAR1A | More | | Hydrocortisone-acetate | hsa04145 | Phagosome | 4.48E-02 | 5 | Q15080, P05164, O60603, P35443, P13765 | NCF4, MPO, TLR2, THBS4, HLA-DOB | More | | Hydrocortisone-acetate | hsa04150 | mTOR signaling pathway | 2.72E-02 | 4 | P42338, Q9NQL2, Q13322, P49841 | PIK3CB, RRAGD, GRB10, GSK3B | More | | Hydrocortisone-acetate | hsa04210 | Apoptosis | 4.11E-03 | 9 | Q13315, P10415, O76075, P01375, Q9NR28, P24522, Q16548, P43234, Q14643 | ATM, BCL2, DFFB, TNF, DIABLO, GADD45A, BCL2A1, CTSO, ITPR1 | More | | Hydrocortisone-acetate | hsa04211 | Longevity regulating pathway | 3.41E-03 | 7 | Q12778, Q08828, P51828, Q99941, P18848, Q9UEF7, Q96KQ7 | FOXO1, ADCY1, ADCY7, CREBL1, ATF4, KL, EHMT2 | More | | Hydrocortisone-acetate | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | | Hydrocortisone-acetate | hsa04217 | Necroptosis | 6.23E-04 | 10 | P01568, P23458, Q13489, Q9NQC7, Q13546, P05141, P01584, P0C0S5, Q13557, Q9H444 | IFNA21, JAK1, BIRC3, CYLD, RIPK1, SLC25A5, IL1B, H2AFZ, CAMK2D, CHMP4B | More | | Hydrocortisone-acetate | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.60E-03 | 7 | Q08828, P51828, Q99941, P18848, P0DP24, Q13557, P23634 | ADCY1, ADCY7, CREBL1, ATF4, CALM2, CAMK2D, ATP2B4 | More | | Hydrocortisone-acetate | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Hydrocortisone-acetate | hsa04340 | Hedgehog signaling pathway | 2.61E-03 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Hydrocortisone-acetate | hsa04380 | Osteoclast differentiation | 6.08E-03 | 10 | Q9NQC7, Q9UQC2, Q16539, P23458, P06239, P42338, P01584, P14778, O75015, Q8N149 | CYLD, GAB2, MAPK14, JAK1, LCK, PIK3CB, IL1B, IL1R1, FCGR3B, LILRA2 | More | | Hydrocortisone-acetate | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Hydrocortisone-acetate | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Hydrocortisone-acetate | hsa04612 | Antigen processing and presentation | 9.00E-05 | 9 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P30511, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, HLA-F, TNF | More | | Hydrocortisone-acetate | hsa04613 | Neutrophil extracellular trap formation | 1.04E-05 | 19 | P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431, Q15080, P20160, P08311, O75015, P21730, O43315, Q16539 | ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, FCGR3B, C5AR1, AQP9, MAPK14 | More | | Hydrocortisone-acetate | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | | Hydrocortisone-acetate | hsa04621 | NOD-like receptor signaling pathway | 4.42E-05 | 18 | Q16539, Q14643, P52630, P01568, Q13489, P10599, Q9H1Y0, P43490, O00463, Q13546, P29728, Q05823, P01375, P09341, P49913, P59665, P59666, P12838 | MAPK14, ITPR1, STAT2, IFNA21, BIRC3, TXN, ATG5, PBEF1, TRAF5, RIPK1, OAS2, RNASEL, TNF, CXCL1, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Hydrocortisone-acetate | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Hydrocortisone-acetate | hsa04623 | Cytosolic DNA-sensing pathway | 5.86E-05 | 4 | P01584, P01568, Q13546, Q8NHW4 | IL1B, IFNA21, RIPK1, CCL4L2 | More | | Hydrocortisone-acetate | hsa04625 | C-type lectin receptor signaling pathway | 2.17E-02 | 3 | P52630, P20749, P01375 | STAT2, BCL3, TNF | More | | Hydrocortisone-acetate | hsa04640 | Hematopoietic cell lineage | 1.10E-02 | 9 | P13612, P14778, P27930, P15144, P25063, P09693, P01732, P13765, P01375 | ITGA4, IL1R1, IL1R2, ANPEP, CD24, CD3G, CD8A, HLA-DOB, TNF | More | | Hydrocortisone-acetate | hsa04650 | Natural killer cell mediated cytotoxicity | 3.18E-05 | 9 | P01375, P06239, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, LCK, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O43451 | MGAM | Maltase-glucoamylase | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.761 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | O43451 | MGAM | Maltase-glucoamylase | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.804 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.869 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | O43451 | MGAM | Maltase-glucoamylase | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.759 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | O43451 | MGAM | Maltase-glucoamylase | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.842 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.762 | O43451 | MGAM | Maltase-glucoamylase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.802 | O43451 | MGAM | Maltase-glucoamylase | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.71 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | O43451 | MGAM | Maltase-glucoamylase | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.71 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 | P01375 | TNF | Tumor necrosis factor | P01375 | TNF | Tumor necrosis factor | 1 | P12429 | ANXA3 | Annexin A3 | P01375 | TNF | Tumor necrosis factor | 0.832 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | P01375 | TNF | Tumor necrosis factor | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.717 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.869 | P12429 | ANXA3 | Annexin A3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.833 | P01375 | TNF | Tumor necrosis factor | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.727 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 | P01375 | TNF | Tumor necrosis factor | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.769 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | P12429 | ANXA3 | Annexin A3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.84 | P01375 | TNF | Tumor necrosis factor | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.754 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.762 | P12429 | ANXA3 | Annexin A3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.919 | P01375 | TNF | Tumor necrosis factor | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.838 | P12429 | ANXA3 | Annexin A3 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.816 | P01375 | TNF | Tumor necrosis factor | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.814 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | P12429 | ANXA3 | Annexin A3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.83 | P01375 | TNF | Tumor necrosis factor | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.814 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 | P12429 | ANXA3 | Annexin A3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.83 |
| Hydrocortisone-acetate | hsa04657 | IL-17 signaling pathway | 3.07E-05 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Hydrocortisone-acetate | hsa04658 | Th1 and Th2 cell differentiation | 2.17E-08 | 12 | Q04759, P07766, P20963, P09693, Q16539, P01730, P06239, Q14765, P23771, Q9UL17, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, CD4, LCK, STAT4, GATA3, TBX21, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | O43451 | MGAM | Maltase-glucoamylase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.771 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | O43451 | MGAM | Maltase-glucoamylase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.799 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P12429 | ANXA3 | Annexin A3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.906 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.852 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.775 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P12429 | ANXA3 | Annexin A3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.769 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.84 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.825 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | P12429 | ANXA3 | Annexin A3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.769 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P12429 | ANXA3 | Annexin A3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.832 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.752 | P12429 | ANXA3 | Annexin A3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.858 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P12429 | ANXA3 | Annexin A3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.76 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.725 |
| Hydrocortisone-acetate | hsa04659 | Th17 cell differentiation | 8.69E-06 | 11 | Q04759, Q16539, P01730, P06239, P13765, P14778, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, MAPK14, CD4, LCK, HLA-DOB, IL1R1, TBX21, GATA3, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | O43451 | MGAM | Maltase-glucoamylase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.924 | O43451 | MGAM | Maltase-glucoamylase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.799 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | O43451 | MGAM | Maltase-glucoamylase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.771 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P12429 | ANXA3 | Annexin A3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.906 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.84 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.825 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P12429 | ANXA3 | Annexin A3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.76 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.936 | P12429 | ANXA3 | Annexin A3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.749 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.752 | P12429 | ANXA3 | Annexin A3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.858 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P12429 | ANXA3 | Annexin A3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.832 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.852 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P12429 | ANXA3 | Annexin A3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.769 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.775 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 |
| Hydrocortisone-acetate | hsa04660 | T cell receptor signaling pathway | 2.32E-06 | 16 | P01375, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | O43451 | MGAM | Maltase-glucoamylase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.764 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | O43451 | MGAM | Maltase-glucoamylase | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.712 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | O43451 | MGAM | Maltase-glucoamylase | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.815 | P12429 | ANXA3 | Annexin A3 | P01375 | TNF | Tumor necrosis factor | 0.832 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P12429 | ANXA3 | Annexin A3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.906 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.751 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P12429 | ANXA3 | Annexin A3 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.77 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | P12429 | ANXA3 | Annexin A3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.836 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.852 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.775 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P12429 | ANXA3 | Annexin A3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.769 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.84 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | P12429 | ANXA3 | Annexin A3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.77 | P12429 | ANXA3 | Annexin A3 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.814 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.825 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | P12429 | ANXA3 | Annexin A3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.743 |
| Hydrocortisone-acetate | hsa04662 | B cell receptor signaling pathway | 2.80E-03 | 6 | P49841, P42338, P60033, P07948, P21854, Q8N149 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Hydrocortisone-acetate | hsa04664 | Fc epsilon RI signaling pathway | 1.80E-02 | 4 | Q16539, P42338, P07948, P09917 | MAPK14, PIK3CB, LYN, ALOX5 | More | | Hydrocortisone-acetate | hsa04668 | TNF signaling pathway | 4.74E-02 | 3 | Q99941, P01584, O95429 | CREBL1, IL1B, BAG4 | More | | Hydrocortisone-acetate | hsa04713 | Circadian entrainment | 1.91E-02 | 4 | P0DP24, Q13557, Q08828, P51828 | CALM2, CAMK2D, ADCY1, ADCY7 | More | | Hydrocortisone-acetate | hsa04720 | Long-term potentiation | 1.91E-02 | 4 | Q13557, P0DP24, P18848, Q08828 | CAMK2D, CALM2, ATF4, ADCY1 | More | | Hydrocortisone-acetate | hsa04723 | Retrograde endocannabinoid signaling | 3.86E-02 | 4 | P63218, P50151, P48058, Q16539 | GNG5, GNG10, GRIA4, MAPK14 | More | | Hydrocortisone-acetate | hsa04724 | Glutamatergic synapse | 7.09E-03 | 5 | P48058, P43003, P63218, P50151, P15104 | GRIA4, SLC1A3, GNG5, GNG10, GLUL | More | | Hydrocortisone-acetate | hsa04725 | Cholinergic synapse | 3.77E-02 | 4 | Q08828, P51828, P18848, Q13557 | ADCY1, ADCY7, ATF4, CAMK2D | More | | Hydrocortisone-acetate | hsa04728 | Dopaminergic synapse | 1.73E-03 | 11 | P63218, P50151, P49841, Q99941, P18848, Q16539, Q13557, P49407, P0DP24, O15516, P48058 | GNG5, GNG10, GSK3B, CREBL1, ATF4, MAPK14, CAMK2D, ARRB1, CALM2, CLOCK, GRIA4 | More | | Hydrocortisone-acetate | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.58E-05 | 10 | P14778, P01584, Q08828, P51828, P22694, Q13557, Q16539, Q14643, Q04759, P0DP24 | IL1R1, IL1B, ADCY1, ADCY7, PRKACB, CAMK2D, MAPK14, ITPR1, PRKCQ, CALM2 | More | | Hydrocortisone-acetate | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Hydrocortisone-acetate | hsa04911 | Insulin secretion | 2.95E-05 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Hydrocortisone-acetate | hsa04912 | GnRH signaling pathway | 6.99E-03 | 5 | Q08828, P51828, P18848, Q13557, P0DP24 | ADCY1, ADCY7, ATF4, CAMK2D, CALM2 | More | | Hydrocortisone-acetate | hsa04915 | Estrogen signaling pathway | 4.72E-02 | 4 | Q99941, P51828, P07900, P11142 | CREBL1, ADCY7, HSP90AA1, HSPA8 | More | | Hydrocortisone-acetate | hsa04916 | Melanogenesis | 7.61E-03 | 4 | Q13557, P0DP24, Q08828, P51828 | CAMK2D, CALM2, ADCY1, ADCY7 | More | | Hydrocortisone-acetate | hsa04918 | Thyroid hormone synthesis | 4.47E-03 | 5 | Q08828, P51828, Q99941, P18848, P02768 | ADCY1, ADCY7, CREBL1, ATF4, ALB | More | | Hydrocortisone-acetate | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Hydrocortisone-acetate | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | | Hydrocortisone-acetate | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Hydrocortisone-acetate | hsa04925 | Aldosterone synthesis and secretion | 8.00E-06 | 7 | Q99941, P18848, Q08828, P51828, P0DP24, Q13557, P23634 | CREBL1, ATF4, ADCY1, ADCY7, CALM2, CAMK2D, ATP2B4 | More | | Hydrocortisone-acetate | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 4 | Q99941, P18848, Q08828, P51828 | CREBL1, ATF4, ADCY1, ADCY7 | More | | Hydrocortisone-acetate | hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.92E-03 | 8 | Q14643, Q08828, P51828, P22694, P23771, Q99941, P18848, P10415 | ITPR1, ADCY1, ADCY7, PRKACB, GATA3, CREBL1, ATF4, BCL2 | More | | Hydrocortisone-acetate | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Hydrocortisone-acetate | hsa04932 | Non-alcoholic fatty liver disease | 3.45E-02 | 5 | P18848, O75460, P01584, P12074, O15239 | ATF4, ERN1, IL1B, COX6A1, NDUFA1 | More | | Hydrocortisone-acetate | hsa04934 | Cushing syndrome | 2.69E-06 | 6 | Q99941, P18848, Q08828, P51828, O15169, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, AXIN1, CAMK2D | More | | Hydrocortisone-acetate | hsa04935 | Growth hormone synthesis, secretion and action | 4.98E-02 | 4 | Q08828, P51828, Q99941, P18848 | ADCY1, ADCY7, CREBL1, ATF4 | More | | Hydrocortisone-acetate | hsa04940 | Type I diabetes mellitus | 1.58E-02 | 2 | P30511, P01375 | HLA-F, TNF | More | | Hydrocortisone-acetate | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Hydrocortisone-acetate | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Hydrocortisone-acetate | hsa04970 | Salivary secretion | 3.54E-02 | 3 | Q08828, P51828, P0DP24 | ADCY1, ADCY7, CALM2 | More | | Hydrocortisone-acetate | hsa04971 | Gastric acid secretion | 2.95E-05 | 5 | Q08828, P51828, P15311, P0DP24, Q13557 | ADCY1, ADCY7, VIL2, CALM2, CAMK2D | More | | Hydrocortisone-acetate | hsa04973 | Carbohydrate digestion and absorption | 1.57E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Hydrocortisone-acetate | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | | Hydrocortisone-acetate | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Hydrocortisone-acetate | hsa05010 | Alzheimer disease | 2.56E-05 | 17 | Q92542, O15239, P05496, Q06055, P12074, Q00535, O75460, P0DP24, P01584, P18848, O15169, P05141, P45880, P17861, P28070, P43686, P62195 | NCSTN, NDUFA1, ATP5G1, ATP5G2, COX6A1, CDK5, ERN1, CALM2, IL1B, ATF4, AXIN1, SLC25A5, VDAC2, XBP1, PSMB4, PSMC4, PSMC5 | More | | Hydrocortisone-acetate | hsa05012 | Parkinson disease | 5.28E-04 | 12 | O15239, P12074, Q06055, P05141, O75460, P18848, P17861, P28070, P43686, P62195, P0DP24, Q13557 | NDUFA1, COX6A1, ATP5G2, SLC25A5, ERN1, ATF4, XBP1, PSMB4, PSMC4, PSMC5, CALM2, CAMK2D | More | | Hydrocortisone-acetate | hsa05014 | Amyotrophic lateral sclerosis | 1.01E-02 | 3 | Q06055, P17861, P62195 | ATP5G2, XBP1, PSMC5 | More | | Hydrocortisone-acetate | hsa05016 | Huntington disease | 3.54E-02 | 8 | O15239, P12074, P24928, P62487, P05141, O75460, P28070, P43686 | NDUFA1, COX6A1, POLR2A, POLR2G, SLC25A5, ERN1, PSMB4, PSMC4 | More | | Hydrocortisone-acetate | hsa05017 | Spinocerebellar ataxia | 1.42E-02 | 2 | P17861, P62195 | XBP1, PSMC5 | More | | Hydrocortisone-acetate | hsa05020 | Prion disease | 1.76E-03 | 12 | P01584, P46531, P11142, O15239, P05496, P12074, P18848, P05141, P45880, P28070, P43686, Q99941 | IL1B, NOTCH1, HSPA8, NDUFA1, ATP5G1, COX6A1, ATF4, SLC25A5, VDAC2, PSMB4, PSMC4, CREBL1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P01584 | IL1B | Interleukin-1 beta | 0.75 | P01584 | IL1B | Interleukin-1 beta | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.827 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.706 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P01584 | IL1B | Interleukin-1 beta | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.783 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.733 | P01584 | IL1B | Interleukin-1 beta | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.744 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.754 | P01584 | IL1B | Interleukin-1 beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.749 | P01584 | IL1B | Interleukin-1 beta | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.768 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.708 | P01584 | IL1B | Interleukin-1 beta | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.734 | P01584 | IL1B | Interleukin-1 beta | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.723 | P01584 | IL1B | Interleukin-1 beta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.704 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.769 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P01584 | IL1B | Interleukin-1 beta | 0.75 | P01584 | IL1B | Interleukin-1 beta | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.827 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.706 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P01584 | IL1B | Interleukin-1 beta | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.783 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.733 | P01584 | IL1B | Interleukin-1 beta | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.744 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.754 | P01584 | IL1B | Interleukin-1 beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.749 | P01584 | IL1B | Interleukin-1 beta | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.768 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.708 | P01584 | IL1B | Interleukin-1 beta | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.734 | P01584 | IL1B | Interleukin-1 beta | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.723 | P01584 | IL1B | Interleukin-1 beta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.704 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.769 |
| Hydrocortisone-acetate | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.12E-04 | 16 | O15239, P12074, Q06055, Q8TEV9, O75460, P18848, P17861, P05141, Q00535, O15169, P01584, P0DP24, Q13557, P28070, P43686, P62195 | NDUFA1, COX6A1, ATP5G2, SMCR8, ERN1, ATF4, XBP1, SLC25A5, CDK5, AXIN1, IL1B, CALM2, CAMK2D, PSMB4, PSMC4, PSMC5 | More | | Hydrocortisone-acetate | hsa05030 | Cocaine addiction | 3.54E-02 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | | Hydrocortisone-acetate | hsa05031 | Amphetamine addiction | 7.61E-03 | 4 | P0DP24, Q13557, Q99941, P18848 | CALM2, CAMK2D, CREBL1, ATF4 | More | | Hydrocortisone-acetate | hsa05034 | Alcoholism | 2.05E-05 | 7 | Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431 | HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Hydrocortisone-acetate | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.61E-03 | 5 | Q16539, P09341, P25024, P25025, P07948 | MAPK14, CXCL1, CXCR1, CXCR2, LYN | More | | Hydrocortisone-acetate | hsa05132 | Salmonella infection | 9.85E-03 | 4 | Q13546, Q13489, O60282, P68371 | RIPK1, BIRC3, KIF5C, TUBB2C | More | | Hydrocortisone-acetate | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Hydrocortisone-acetate | hsa05134 | Legionellosis | 5.53E-03 | 2 | Q9NR31, P68104 | SAR1A, EEF1A1 | More | | Hydrocortisone-acetate | hsa05135 | Yersinia infection | 1.11E-03 | 8 | P13612, P06239, Q16539, P01375, P42338, P49841, P01730, P01732 | ITGA4, LCK, MAPK14, TNF, PIK3CB, GSK3B, CD4, CD8A | More | | Hydrocortisone-acetate | hsa05140 | Leishmaniasis | 1.99E-03 | 7 | P13612, O75015, P13765, O60603, P01375, P49006, Q16539 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MARCKSL1, MAPK14 | More | | Hydrocortisone-acetate | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Hydrocortisone-acetate | hsa05144 | Malaria | 9.96E-05 | 7 | P60033, P69905, P68871, O60603, P01375, P35443, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Hydrocortisone-acetate | hsa05146 | Amoebiasis | 1.14E-04 | 9 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P12814, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, ACTN1, CTSG | More | | Hydrocortisone-acetate | hsa05150 | Staphylococcus aureus infection | 1.02E-03 | 7 | P21730, P21462, O75015, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Hydrocortisone-acetate | hsa05160 | Hepatitis C | 9.27E-03 | 4 | P52630, P60033, P49841, P01375 | STAT2, CD81, GSK3B, TNF | More | | Hydrocortisone-acetate | hsa05163 | Human cytomegalovirus infection | 1.21E-07 | 22 | P42338, P01375, P63218, P50151, Q14643, P0DP24, Q8NHW4, Q08828, P51828, P22694, P23458, P49841, P14778, P01584, P61073, Q13651, P25025, Q16539, Q99941, P18848, P04637, O00463 | PIK3CB, TNF, GNG5, GNG10, ITPR1, CALM2, CCL4L2, ADCY1, ADCY7, PRKACB, JAK1, GSK3B, IL1R1, IL1B, CXCR4, IL10RA, CXCR2, MAPK14, CREBL1, ATF4, TP53, TRAF5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P01584 | IL1B | Interleukin-1 beta | P0DP24 | CALM2 | Calmodulin-2 | 0.72 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.75 | P01584 | IL1B | Interleukin-1 beta | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.815 | P01584 | IL1B | Interleukin-1 beta | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.799 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P01584 | IL1B | Interleukin-1 beta | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.825 | P01584 | IL1B | Interleukin-1 beta | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.82 | P01584 | IL1B | Interleukin-1 beta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.704 | P01584 | IL1B | Interleukin-1 beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.749 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.751 | P12429 | ANXA3 | Annexin A3 | P01375 | TNF | Tumor necrosis factor | 0.832 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.733 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.875 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.728 | P12429 | ANXA3 | Annexin A3 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.75 | P01584 | IL1B | Interleukin-1 beta | P0DP24 | CALM2 | Calmodulin-2 | 0.72 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.75 | P01584 | IL1B | Interleukin-1 beta | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.815 | P12429 | ANXA3 | Annexin A3 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.754 | P01584 | IL1B | Interleukin-1 beta | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.799 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | P12429 | ANXA3 | Annexin A3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.936 | P12429 | ANXA3 | Annexin A3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.749 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P01584 | IL1B | Interleukin-1 beta | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.825 | P01584 | IL1B | Interleukin-1 beta | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.82 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.769 | P12429 | ANXA3 | Annexin A3 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.716 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.889 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.86 | P12429 | ANXA3 | Annexin A3 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.857 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | P01584 | IL1B | Interleukin-1 beta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.704 | P01584 | IL1B | Interleukin-1 beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.749 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.719 | P12429 | ANXA3 | Annexin A3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.896 |
| Hydrocortisone-acetate | hsa05165 | Human papillomavirus infection | 1.76E-02 | 5 | P49841, P24821, P01375, P52630, P30511 | GSK3B, TNC, TNF, STAT2, HLA-F | More | | Hydrocortisone-acetate | hsa05169 | Epstein-Barr virus infection | 2.32E-02 | 9 | Q13547, O00463, Q16539, P42338, P07948, Q13761, P24522, P07766, P20963 | HDAC1, TRAF5, MAPK14, PIK3CB, LYN, RUNX3, GADD45A, CD3E, CD247 | More | | Hydrocortisone-acetate | hsa05202 | Transcriptional misregulation in cancer | 4.24E-04 | 16 | Q12778, Q13315, P14780, P27930, Q15744, Q16548, P11215, O15550, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, P12980, P24522 | FOXO1, ATM, MMP9, IL1R2, CEBPE, BCL2A1, ITGAM, UTX, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, LYL1, GADD45A | More | | Hydrocortisone-acetate | hsa05203 | Viral carcinogenesis | 2.10E-04 | 8 | Q12933, P42229, Q13547, Q15283, P58876, P62807, Q16778, O60814 | TRAF2, STAT5A, HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | | Hydrocortisone-acetate | hsa05204 | Chemical carcinogenesis | 1.77E-04 | 4 | Q16772, P09211, P78417, P11712 | GSTA3, GSTP1, GSTO1, CYP2C9 | More | | Hydrocortisone-acetate | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | | Hydrocortisone-acetate | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Hydrocortisone-acetate | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Hydrocortisone-acetate | hsa05230 | Central carbon metabolism in cancer | 1.12E-02 | 1 | P11413 | G6PD | More | | Hydrocortisone-acetate | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 7.43E-06 | 11 | P42338, O95267, P07766, P20963, P09693, P06239, O60603, P10747, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, CD3E, CD247, CD3G, LCK, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.751 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.716 | P12429 | ANXA3 | Annexin A3 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.77 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.852 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.775 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.744 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P12429 | ANXA3 | Annexin A3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.769 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.825 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P12429 | ANXA3 | Annexin A3 | O60603 | TLR2 | Toll-like receptor 2 | 0.702 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P12429 | ANXA3 | Annexin A3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.906 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.707 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.84 |
| Hydrocortisone-acetate | hsa05310 | Asthma | 5.14E-04 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Hydrocortisone-acetate | hsa05321 | Inflammatory bowel disease | 3.54E-06 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Hydrocortisone-acetate | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 7 | P09871, Q93077, P58876, P62807, Q16778, O60814, P68431 | C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Hydrocortisone-acetate | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Hydrocortisone-acetate | hsa05330 | Allograft rejection | 2.30E-02 | 2 | P30511, P01375 | HLA-F, TNF | More | | Hydrocortisone-acetate | hsa05332 | Graft-versus-host disease | 1.82E-05 | 6 | P13765, P30511, P10747, P01375, P26715, Q13241 | HLA-DOB, HLA-F, CD28, TNF, KLRC1, KLRD1 | More | | Hydrocortisone-acetate | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Hydrocortisone-acetate | hsa05415 | Diabetic cardiomyopathy | 3.59E-02 | 1 | P11413 | G6PD | More | | Hydrocortisone-acetate | hsa05418 | Fluid shear stress and atherosclerosis | 3.86E-03 | 8 | Q16539, Q14145, P10599, P14780, P01375, P04637, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2 | More | | |